Logo

American Heart Association

  2
  0


Final ID: Su2126

Relationship between Cardiac Implantable Electronic Devices and Tricuspid Regurgitation in the General Population

Abstract Body (Do not enter title and authors here): Introduction
Case series suggest that cardiac implantable electronic devices (CIEDs) with right ventricular leads may tether the tricuspid valve, leading to clinically relevant tricuspid regurgitation (TR). However, the impact of these devices on tricuspid disease in the general population has not been investigated.

Methods
Using California’s Department of Health Care Access and Information databases, a longitudinal Cox proportional-hazards analysis of adults who received care in an emergency department, hospital, or outpatient surgery facility from 1 January 2005 to 31 December 2020 was performed. Patients with prevalent TR, rheumatic or congenital heart disease, and endocarditis were excluded. Outcomes were (1) the development of TR and (2) tricuspid intervention.

Results
Of 16,893,314 participants contributing 56,095,327 person years, there were 11,234 instances of TR. In the unadjusted analyses, CIED implantation was associated with a 13-fold higher risk of incident TR. After adjusting for age, sex, race and ethnicity, income, heart failure, atrial fibrillation, hypertension, pulmonary hypertension, coronary artery disease, chronic kidney disease, hyperlipidemia, diabetes mellitus, chronic obstructive pulmonary disease, asthma, obstructive sleep apnea, alcohol use, cocaine use, methamphetamine use, opiate use, and tobacco use, patients with a CIED exhibited a 15% higher risk of TR (Figure 1). Heart failure, pulmonary hypertension, hypertension, and atrial fibrillation each exhibited larger magnitudes of risk for TR than having a CIED.

In the same population, 74 tricuspid valve interventions were identified. While a CIED was associated with a subsequent tricuspid intervention with HR 19.43 (p<0.0001) in the unadjusted model, this lost statistical significance after adjusting for the same covariates listed above (HR 1.3, p=0.34).

Conclusions
Patients with a CIED experienced a higher risk of TR, although the magnitude of the hazard was smaller than other cardiovascular risk factors. While the point estimate favored a higher risk of requiring tricuspid interventions among those with CIEDs, statistical significance was lost after multivariable adjustment, likely due to a small number of outcomes.
  • Bowman, Hilary  ( UCSF , San Francisco , California , United States )
  • Tang, Janet  ( UCSF , San Francisco , California , United States )
  • Thein, Anna-sophie  ( UCSF , San Francisco , California , United States )
  • Dewland, Thomas  ( UCSF , San Francisco , California , United States )
  • Marcus, Gregory  ( UCSF , San Francisco , California , United States )
  • Author Disclosures:
    Hilary Bowman: DO NOT have relevant financial relationships | Janet Tang: DO NOT have relevant financial relationships | Anna-Sophie Thein: DO NOT have relevant financial relationships | Thomas Dewland: DO NOT have relevant financial relationships | Gregory Marcus: DO have relevant financial relationships ; Consultant:InCarda:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Improvements in Cardiac Implantable Electronic Device Therapies

Sunday, 11/17/2024 , 03:15PM - 04:15PM

Abstract Poster Session

More abstracts on this topic:
Clinical impact of new severe tricuspid regurgitation following device lead extraction

Arunachalam Karikalan Suganya, M Ezzedine Fatima, Desimone Christopher, Sugrue Alan, Padang Ratnasari, El Masry Hicham, Lee Justin, Deshmukh Abhishek, O'shea Michael, Vemulapalli Hema Srikanth, Mulpuru Siva, Killu Ammar, Siontis Konstantinos, Kowlgi Gurukripa, Cha Yong, Madhavan Malini

Non-ischemic septal fibrosis on delayed enhancement CMR provides incremental prognostic value in functional tricuspid regurgitation

Villar Calle Pablo, Mayol Josep, Falco Giorgia, Weinsaft Jonathan, Kim Jiwon, Pai Varun, Kochav Jonathan, Chiu Caitlin, Axman Rachel, Sahai Aditya, Reza Mahniz, Ruoli Letizia, Khalique Omar

More abstracts from these authors:
Coffee and Calesthenics: AF Risk Factor Modification - Where do we stand?

Sanders Prashanthan, Marcus Gregory, Piccini Jonathan

Atrial Fibrillation in Valvular Heart Disease: Assessing the Impact of Genetics in the UK Biobank

Cristin Luca, Tang Janet, Tastet Lionel, Marcus Gregory, Delling Francesca

You have to be authorized to contact abstract author. Please, Login
Not Available